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Summary 
Using the cytoplasmic domain of Fas in the yeast two- 
hybrid system, we have identified a novel interacting 
protein, FADD, which binds Fasand Fas-FD5, a mutant 
of Fas possessing enhanced killing activity, but not the 
functionally inactive mutants Fas-LPR and Fas-FD8. 
FADD contains a death domain homologous to the 
death domains of Fas and TNFR-1. A point mutation 
in FADD, analogous to the Ipr mutation of Fas, abol- 
ishes its ability to bind Fas, suggesting a death domain 
to death domain interaction. Overexpression of FADD 
in MCF7 and BJAB cells induces apoptosis, which, like 
Fas-induced apoptosis, is blocked by CrmA, a specific 
inhibitor of the interleukin-1fMonverting enzyme. 
These findings suggest that FADD may play an im- 
portant role in the proximal signal transduction of Fas. 
Introduction 
Programmed cell death (PCD) is a physiological process 
essential to the normal development and homeostatic 
maintenanceof multicellular organisms (reviewed by Vaux 
et al., 1994; Ellis et al., 1991). Apoptosis, often equated 
with PCD, refers to the morphological alterations exhibited 
by “actively” dying cells that include cell shrinkage, mem- 
brane blebbing, and chromatin condensation (Cohen, 
1993). In contrast, necrosis, sometimes referred to as acci- 
dental cell death, is defined by the swelling and lysis of 
cells that are exposed to toxic stimuli. 
Though the morphological features of cell death are well 
described, the molecular mechanisms behind apoptosis 
remain undefined. Recent work on PCD in the nematode 
Caenorhabditis elegans showed that the ted-3 gene is 
required for apoptosis (Yuan et al., 1993). Sequence anal- 
ysis revealed that CED3 is similar to the mammalian in- 
terleukin-18 (IL-18)-converting enzyme (ICE) (Yuan et al., 
1993), which is a cysteine proteinase involved in the pro- 
cessing and activation of pro-IL-l 8 to the active cytokine 
(Cerretti et al., 1992; Thornberry et al., 1992). Overexpres- 
sion of ICE in mammalian cells induced apoptosis, sug- 
gesting that ICE, or a related protease, may be an essential 
component of the cell death pathway (Miura et al., 1993). 
Although a CED-3-like protease is suspected to be a 
distal effector of the mammalian cell death pathway, the 
proximal components that lead to its activation remain to 
be identified. Two cell surface cytokine receptors, Fasl 
APO-l antigen and the receptor for tumor necrosis factor 
*The first two authors contributed equally to this work. 
(TNF), have been shown to trigger apoptosis by natural 
ligands or specific agonist antibodies (Baglioni, 1992; Yo- 
nehara et al., 1989; ltoh et al., 1991; Trauth et al., 1989). 
Mice carrying a point mutation in the cytoplasmic domain 
of Fasexhibit a lupus-like lymphoproliferativeautoimmune 
disorder (/or), (Watanabe-Fukunaga et al., 1992), and the 
Fas-mediated cell death pathway has been recently impli- 
cated in the activation-induced death of T cells (Dhein et 
al., 1995; Brunner et al., 1995; Ju et al., 1995). While the 
main activity of Fas is to trigger cell death, the TNF recep- 
tor (TNFR) can signal an array of diverse activities such 
as fibroblast proliferation, resistance to chlamidiae, and 
synthesis of prostaglandin E2 (Tartaglia and Goeddel, 
1992). Recent work in our laboratory suggests that the 
stimulation of Fas or the TNFR triggers the activation of 
a common component of the cell death pathway. CrmA, 
a poxvirus gene product, was shown to potently block both 
Fas- and TNF-induced cell death (Tewari and Dixit, 1995). 
Interestingly, the only reported target for CrmA is the 
CED-3 homolog ICE (Ray et al., 1992) suggesting that 
ICE, or an ICE-like protease, is the common effector of 
cytokine receptor-mediated cell death. 
The activation of Fas and TNFR is caused by receptor 
aggregation mediated by the respective ligands or agonist 
antibodies. The signal is thought to be transduced by clus- 
tering of the intracellular domain (Boldin et al., 1995; Song 
et al., 1994), which encompasses a region that is signifi- 
cantly conserved in the Fas antigen as well as in TNFR-1 
(Tartaglia et al., 1993; ltoh and Nagata, 1993). This shared 
“death domain” suggests that both receptors interact with 
a related set of signal transduction molecules that, thus 
far, remain unidentified. 
Here, we report the molecular cloning and characteriza- 
tion of FADD, a Fas-associating protein with a novel death 
domain. The specific interaction of Fas and FADD is due 
to the association of their respective homologous death 
domains. Remarkably similar to Fas-induced killing, over- 
expression of FADD induces apoptosis that is inhibitable 
by CrmA. Taken together, our results suggest that FADD 
is a component of the Fas-mediated cell death pathway. 
Results 
Isolation of FADD 
The yeast two-hybrid system was used to screen for pro- 
teins that interact with the cytoplasmic domain of Fas. An 
expression vector was constructed by fusing the GAL4 
DNA-binding domain to the cytoplasmic tail of the human 
Fas antigen (GAL4bd-Fas). This bait plasmid was cotrans 
formed in yeast with a prey plasmid containing a human B 
cell cDNA expression library fused to the GAL4 activation 
domain. Seventeen positive clones were obtained from 
2 x 1 O6 transformants screened. To determine the speci- 
ficity of interaction, plasmids containing the activation do- 
main fusion proteins were recovered from the putative pos- 
itive clones and cotransformed with GAL4bd-Fas and 









Figure 1. FADD Specifically Interacts with the Cytoplasmic Domain 
of Fas in Yeast 
P-Galactosidase filter assays performed on Y190 yeast expressing the 
GAL4 activation domain-FADD fusion protein and indicated heterolo- 
gous GAL4 DNA-binding domain fusion proteins, 
found to interact with the GAL4 DNA-binding domain fu- 
sion protein containing the cytoplasmic domain of wild- 
type Fas and not the functionally inactive deletion mutant 
Fas-FD8 (Itoh and Nagata, 1993) or the indicated heterolo- 
gous baits (Figure 1). 
FADD is a Novel Protein with a Death Domain 
Clones 8 and 15 isolated by the yeast two-hybrid screen 
were found to contain overlapping sequence fused to the 
GAL4 activation domain in the same reading frame. To 
obtain a full-length coding sequence, a human umbilical 
vein endothelial cell (HUVEC) library was screened with 
a cDNA insert obtained from clone 15. Two independent 
clones yielded a 1.6 kb cDNA containing an open reading 
frame that begins with an initiator methionine conforming 
to Kozak’s consensus (Kozak, 1989) and that ends 625 nt 
later at an Opal codon. Given the presence of an in-frame 
stop codon 130 bp upstream of the initiator methionine 
and the size of the transcript (1.6 kb; Figure 3) it is likely 
that Figure 2A represents the full-length coding sequence. 
This gene encodes a previously undescribed protein of 
208 amino acids with a predicted molecular mass of 23.3 
kDa, designated FADD. 
A BLAST search revealed that residues 11 l-170 of 
FADD matched residues 233-292 of rat Fas antigen (rFas, 
p = 0.0012) and shared 27% identity (51% of the amino 
acids were conserved). This region in the cytoplasmic do- 
main of rFas corresponds to the death domain, a region 
of homology shared by both Fas and TNFR-1 that signals 
cell death (Tartaglia et al., 1993; ltoh and Nagata, 1993). 
Dependent upon the alignment and boundaries se- 
lected, the death domains of FADD, Fas, and TNFR-1 
share 25%-30% identity (Figure 28). When conservative 
amino acid substitutions are included, the homologies ap- 
proach 50%. These values are consistent with those pre- 
viously reported for the death domain homology between 
TNFR-1 and Fas (Tartaglia et al., 1993; ltoh and Nagata, 
1993). Interestingly, V121 of FADD is aligned and con- 
Figure 2. Sequence Analysis of FADD and Its Novel Death Domain 
(A) The deduced amino acid sequence of the FADD protein product. 
The N-termini of clones 6 and 15 isolated in the yeast two-hybrid screen 
are indicated with arrows. The death domain is underlined, and the 
valine residue altered to an asparagine in FADDmt is indicated by the 
closed triangle. 
(6) The death domain of FADD and its amino acid sequence homology 
to other death domains. Solid black shading refers to identical resi- 
dues, and gray shading indicates conservative amino acid substitu- 
tions relative to the sequence of FADD. The arrow indicates the amino 
acid residue, which when substituted by an asparagine, disrupts bind- 
ing, signaling, or both in the respective proteins. 
served with V238 of Fas, which when altered to an aspara- 
gine, abolishes the cell-killing activity of Fas and in mice 
is responsible for the lymphoproliferation (Ipr) phenotype 
(Watanabe-Fukunaga et al., 1992). A corresponding inac- 
tivating mutation also exists in TNFR-1, L351+N351 (Tar- 
taglia et al., 1993). 
Tissue Distribution of FADD 
Northern blot analysis revealed that FADD is constitutively 
expressed in many fetal and adult human tissues (Figure 
3). The mRNA transcript is approximately 1.6 kb, consis- 
tent with the size of the cDNA clones isolated from the 
HUVEC library. 
In Vitro Association of FADD and Fas 
To confirm the interaction observed in yeast, radiolabeled 
in vitro translated FADD was precipitated with various glu- 
tathione S-transferase (GST) fusion proteins immobilized 
on glutathione-Sepharose beads (Figures 4A and 4B). As 
predicted, FADD specifically associated with GST-Fas 
but not GST, GST-Fas-FD8, or GST-Fas-LPR, which con- 
tains the cytoplasmic domain of the functionally inactive 
point mutant of Fas (Itoh and Nagata, 1993). A very weak 
interaction was observed between FADD and TNFR-1. In- 
terestingly, relative to its association with GST-Fas, FADD 
strongly interacted with GST-Fas-FD5, which is a 15 
amino acid C-terminal deletion mutant of Fas possessing 
enhanced killing activity (Itoh and Nagata, 1993). Similar 
results were obtained when detergent lysates of 293Tcells 
expressing FADD were precipitated with the various GST 
fusion proteins (Figure 4C). 
Coimmunoprecipitation of FADD and Fas 
To demonstrate the interaction of FADD and Fas in vivo, 
293T cells were transiently transfected with HA epitope- 
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Figure 3. FADD Is Expressed in a Variety of Tissues and Develop- 
mental Stages 
(A) A human adult tissue Northern blot (Clontech) was probed with 
FADD cDNA. PBL, peripheral blood leukocyte. 
(B) A human fetal Northern blot (Clontech) was probed as in (A). 
tagged FADD (HA-FADD) and FLAG epitope-tagged Fas 
(FLAG-Fas) and mutants (Figure 5). Expression of the 
FLAG-tagged constructs was shown by immunoprecipita- 
tion with an anti-FLAG (a-FLAG) antibody (Figure 5B). 
Likewise, immunoprecipitation with anti-HA (a-HA) anti- 
body showed expression of HA-FADD, and as expected, 
FLAG-Fas and FLAG-Fas-FD5 individually coprecipitated, 
while the functionally inactive mutants FLAG-Fas-FD8 and 
FLAG-Fas-LPR did not (Figure 5C). The a-HA immunopre- 
cipitates were dissociated and subjected to a second 
round of immunoprecipitation with a-FLAG antibody. Con- 
sistent with results of the primary immunoprecipitation 
(with a-HA), a double immunoprecipitation with a-HA fol- 
lowed by a-FLAG confirmed the presence of FLAG-Fas 
and FLAG-Fas-FD5 in the original immune complexes 
(Figure 5D). 
The Death Domain of FADD Interacts 
with the Death Domain of Fas 
Previous studies have reported that the death domains of 
TNFR-1 and Fas self-associate (Boldin et al., 1995). The 
two clones (8 and 15) isolated in our two-hybrid screen 
(using the cytoplasmic domain of Fas as bait) did not con- 
tain various portions of the N-terminus of wild-type FADD 
(Figure 2A). The shortest of the two, clone 8, is missing the 
N-terminal 40 amino acids, suggesting that the C-terminal 
half of FADD, which contains the death domain, interacts 
with the cytoplasmic tail of Fas. More specifically, our re- 
sults show that FADD interacts with the death domain of 
Fas, since it fails to associate with Fas-LPR and Fas-FD8, 
a point mutant and deletion mutant, respectively, of the 
Fas death domain. 
Thus, it is reasonable to propose that the death domain 
of FADD is interacting with its homologous counterpart in 
Fas. To test this hypothesis, we engineered a point mutant 
of FADD (FADDmt) in which V121 is altered to an aspara- 
gine. This mutation corresponds to the inactivating Ipr 
mutation (V238eN238) of Fas and the L351 -+N351 muta- 
tion of TNFR-1. 293T cells were transiently transfected 
with expression constructs containing AU1 epitope-tagged 
FADD (AUl-FADD) and AUl-FADDmt. Detergent lysates 
were prepared and subsequently precipitated with GST, 
GST-Fas, and GST-Fas-LPR immobilized on glutathi- 
one-Sepharose beads (Figure 6). As predicted, AUl- 
Figure 4. Specific Interaction of GST-Fas and GST-Fas-FD5 with In 
Vitro Translated FADD and FADD Expressed in Transfected 293T 
Cells 
(A) Schematic representation of the GST fusion proteins containing 
the cytoplasmic domains of Fas, Fas mutants, and TNFR-1. Amino 
acid residues are given for selected junctions, and numbering is based 
on the mature form of the receptor. The Ipf mutant (V238+N238) of 
Fas is represented by an asterisk. Gray shading represents the death 
domain of Fas. Binding of FADD to the various GST fusion proteins 
is depicted at the right and is based on data from (B). 
(B) Interaction of in vitro translated, %-labeled FADD with various 
GST fusion proteins immobilized on glutathione-Sepharose beads. 
After the beads were washed, retained FADD protein was analyzed 
by SDS-PAGE and autoradiography (upper panel). The gel was Coo- 
massie stained, and the bands representing the various GST fusion 
proteins were aligned to show equivalency of loading (lower panel). 
(C) 293T cells were transfected with HA epitope-tagged FADD (HA- 
FADD) and metabolically labeled with [“Sjmethionine and cysteine. 
Detergent lysates were prepared and incubated with the various GST 
fusion proteins immobilized on glutathione-Sepharose beads. After 
washing, the complexed beads were dissociated and immunoprecipi- 
tated with an anti-HA (a-HA) antibody that should recognize HA-FADD. 
The samples were then analyzed by SDS-PAGE and autoradiography 
(upper panel). The respective GST fusion proteins are shown as in 
(B) (lower panel). 
FADD bound GST-Fas and not GST or GST-Fas-LPR, 
while, in contrast, AUl-FADDmt failed to bind any of the 
GST fusions. Taken together, our results suggest that a 
death domain to death domain interaction is responsible 
for the association of FADD and Fas. 
Overexpression of FADD Initiates Apoptosis 
That Is Suppressed by CrmA 
To study the functional role of FADD, we chose MCF7 
cells, a breast carcinoma cell line that expresses Fas 
and is sensitive to Fas-induced killing in the presence of 
the protein synthesis inhibitor cycloheximide (Tewari and 
Dixit, 1995). Two stably transfected and previouslycharac- 
terized clonal cell lines of MCF7 were used in our study: 
one expresses CrmA, a viral serpin inhibitor that has been 
shown to potently block Fas-mediated cell death (Tewari 
and Dixit, 1995) and a corresponding control cell line ex- 
presses an inactive CrmA mutant (Tewari et al., submit- 
ted). The mutant CrmA possesses a single amino acid 
substitution within its reactive site loop, abolishing its abil- 
ity to inhibit Fas- and TNF-mediated apoptosis. The re- 
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A Figure 5. In Vivo Association of FADD with Fas and Fas-FD5 E.trr.ll”l.r Drd” Cywll..rnh DOm.*n 
* 4 * FADD Cell (A) Schematic representation of Fas and Fas mutants transfected into &Lc4i!x d&g 293T cells. The closed square represents the FLAG epitope tag engi- 
CL.. r III- hF.l 1 
ti 
neered five amino acids downstream of the putative signal sequence 
of Fas. The open rounded rectangles represent the three cysteine-rich 
subdomains of the extracellular domain of Fas, while the cytoplasmic 
residues contain the death domain (gray rectangle) and a putative 
negative regulatory domain (shaded oval). Residue numbering is 
based on the mature form of the receptor and the amino acid sequence 
is given for selected junctions. The Ipr mutant (V238-N238) of Fas 
is represented by an asterisk. In vivo FADD binding is described to 
D the right of the schematic (based on ID]) along 
I % 8 
with relative cell death caused by Fas and its 
z:;g _.: 2 s i 
mutants as described by ltoh and Nagata 
I I  l 1 (1993). 
(6) 293T cells were cotransfected with HA- 
FADD and FLAG epitope-tagged Fas and Fas 
mutants (as depicted in [A]) and metabolically 
labeled with [*S]methionine and cysteine. De- 
tergent lysates were then immunoprecipitated 
with anti-FLAG (a-FLAG) monoclonal antibody 
and isotype-matched control antibody and analyzed by SDS-PAGE and autoradiography to show expression of FLAG-tagged Fas and Fas mutants. 
White asterisks indicate relative position of Fas and its mutants. 
(C) 293T lysates (as in [B]) were also immunoprecipitated with a-HA antibody to show HA-FADD expression. 
(D) Coimmunoprecipitation of FADD with Fas and mutants. A fraction of the a-HA immunoprecipitates (used in [C]) were dissociated and reimmunoprecipi- 
tated with an a-FIAG antibody. 
spective MCF7 cell lines were transiently transfected with 
a FADD expression vector in the presence of an equimolar 
amount of the pCMV f3-galactosidase reporter and exam- 
ined by phase contrast microscopy 24 hr later. The MCF7I 
mutant CrmA cell lines expressing FADD @-galactosi- 
dase-positive blue cells) displayed morphological alter- 
ation typical of adherent cells undergoing apoptosis, be- 
coming rounded, condensed, and detaching from the dish 
(Figure 7A, left). The nuclei of the rounded MCF7 cells 
exhibited apoptotic morphology indistinguishable from 
MCF7 cells treated with anti-Fas antibody in the presence 
of cycloheximideasassessed bypropidium iodidestaining 
(data not shown). In contrast, MCF7/CrmA cells trans- 
fected with FADD were significantly protected from cell 
death and the accompanying morphological alterations of 
apoptosis (Figure 7A, right). A quantitative representation 
of this data is shown in Table 1. 
FADD-induced apoptosis is not peculiar to MCF7 cells, 
since a similar phenotype was observed in the B cell 
lymphoma cell line, BJAB, which is exquisitely sensitive 
to anti-Fas antibody-induced apoptosis (Tewari and Dixit, 
1995). CrmA-expressing and vector control BJAB cell lines 
(Tewari and Dixit, 1995) were transfected with the pCMV 
f3-galactosidase reporter in the presence or absence of an 
equimolar amount of an expression construct encoding 
FADD. As expected, expression of P-galactosidase alone 
in both the CrmA and vector clones did not induce apop- 
totic cell death as assessed by propidium iodide staining 
of nuclei of f&galactosidase-positive cells (data not shown). 
In contrast, however, the vector control cell line cotrans- 
fected with pCMV f3-galactosidase and pcDNA3 AUl- 
FADD exhibited prominent apoptotic morphology includ- 
ing chromatin condensation and cellular shrinkage. More 
importantly, FADD-induced apoptosis, like Fas-induced 
apoptosis, was inhibited in the CrmA-expressing line. In 
the vector control lines, over 90% of the transfected cells 
AUI-FAOD AM-FADDmt 
Figure 8. FADDmt Fails to Bind Fas, Suggesting a Death Domain to 
Death Domain Interaction 
293T cells were transfected with AU1 epitope-tagged FADD (AUI- 
FADD) or AU1 -FADDmt and metabolically labeled with [%]methionine 
and cysteine. Detergent lysates were prepared and incubated with 
various GST fusion proteins immobilized on glutathione-Sepharose 
beads. The samples were analyzed by SDS-PAGE and autoradiogra- 
phy (upper panel). The respective GST fusion proteins are shown as 
in Figure 48 (middle panel). To show that equivalent amounts of AUl- 
FADD and AUl-FADDmt were expressed and subsequently incubated 
with the beads, an aliquot of the respective lysates was immunoprecipi- 
tated with a-AU1 antibody and visualized by SDS-PAGE and autoradi- 
ography (bottom panels). 
expressing FADD were apoptotic, while less then 10% 
exhibited similar morphology in the corresponding CrmA- 
expressing lines (Table 1). As a control, expression of AU1 - 
TRAFl (Rothe et al., 1994) and HACD40bp (Hu et al., 
1994), which a8sociate with the cytoplasmic domains of 
TNFR-2 and CD40, respectively, revealed less than 10% 
apoptotic morphology in either the CrmA or vector cell 
lines. 
Delineation of the Death Effector Domain of FADD 
Deletion mutants of FADD were constructed to determine 
the region responsible for initiating the cell death program 
(Figure 78). As described above, MCF7 cells expressing 
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CrmA and mutant CrmA were transiently transfected with 
the various FADD mutant expression vectors. Interest- 
ingly, overexpression of FADDmt, a point mutant that fails 
to bind Fas, still induced cell death that was CrmA inhibit- 
able and, in fact, was slightly more potent than wild-type 
FADD (81% versus 72% apoptotic cells). A FADD mutant 
(N-FADD) containing only 117 N-terminal amino acids was 
able to trigger cell death (Table 1; Figure 78). Since a 
large portion of the death domain is absent from N-FADD, 
Cdl it is not surprising that it, like FADDmt, fails to associate 
with the cytoplasmic domain of Fas (data not shown). 
N-terminal deletions of FADD (NFD-2, NFD-3, and NFD-4) 
attenuated its ability to induce cell death (Table 1; Figure 
+ 78). This analysis suggests that, whereas the Fas- 
* interacting domain is in the C-terminal half of FADD, the 
death effector domain lies in its N-terminal portion. 
Discussion 
FADD was identified as a novel protein that associates 
specifically with the cytoplasmic domain of Fas in the yeast 
two-hybrid screen (Figure 1). A BLAST search using the 
amino acid sequence of FADD revealed a stretch of 80 
amino acids that were significantly homologous to the 
Figure 7. Functional Effects of Expression of FADD and mutants in 
MCF7 Cells 
(A, left) Overexpression of FADD and !3-galactosidase in MCF7/mutant 
CrmA cells. (Right) Overexpression of FADD and P-galactosidase in 
MCF7/CrmA cells. Cells were stained with X-Gal and examined by 
phase contrast microscopy. See Table 1 for details. 
(B) Schematic representation of FADD and mutants. Amino acid resi- 
dues are given for selected junctions. The point mutation of FADD 
(V121-+N12l)isrepresented by an asterisk. Thegrayand blackrectan- 
gles represent the death domain of FADD and an AU1 epitope tag, 
respectively. Ability of the various mutants to induce cell death in MCF7 
cells is described to the right of the schematic and is based on data 
from Table 1. 
death domain of Fas (Figure 28). When this region of 
FADD was masked, the remaining sequences did not 
match any proteins in the data base. Interestingly, BLAST 
searches using the death domains of FADD, Fas, and 
TNFR-1 revealed a significant homology to the family of 
ankyrins (p < 0.001 for all three death domains) that medi- 
ate interaction between integral membrane components 
and cytoskeletal elements. More specifically, the respec- 
tive death domains aligned with approximately 80 amino 
acids of the negative regulatory domain of ankyrin. A previ- 
ous study reported that this region of ankyrin is homolo- 
Table 1. The Effects of Overexpressing FADD and FADD Mutants in MCF7 and BJAB Cells 
Cell Lines 
MCF7/CrmA Mutant MCF7/CrmA BJABNector BJABlCrmA 
t3-galactosidase alone 12.9 5 3.8 7.7 + 4.0 6.0 k 4.3 7.4 f 4.3 
AUl-FADD 72.1 t 1.2 15.6 f 4.8 91.6 f 2.0 6.2 f 3.6 
AUl-FADDmt 81.2 + 2.9 13.8 f a.4 ND ND 
AUI-N-FADD 69.9 f 1.7 10.4 f 6.1 ND ND 
AUl-NFDP 24.0 f 8.8 10.9 f 8.0 ND ND 
AUI-NFDPI6 13.6 f 1.4 12.1 k 7.5 ND ND 
AUl-NFD3 29.6 * 4.2 13.0 f 8.8 ND ND 
AUl-NFD4 21.2 + 1.7 11.2 f 6.2 ND ND 
AUl-TRAFl ND ND 5.5 f 0.9 6.8 f 2.6 
AUlCD40bp ND ND 10.8 f 1.2 9.7 + 1.4 
Two previously characterized MCF7 and BJAB cell lines expressing CrmA and either a corresponding vector control line (Tewari and Dixit, 1995) or 
mutant CrmA line (Tewari et al., submitted) were transiently transfected with pCMV+galactosidase in the presence or absence of an approximately 
equimolar quantity of pcDNA3 (Invitrogen) expression constructs encoding AUI-FADD, FADD mutants (as designated in Figure 7B), AUl-TRAFl 
(Rothe et al., 1994) or HACD40bp (Hu et al., 1994). After transfection (24 hr), MCF7 cells were fixed with 0.5% glutaraldehyde and stained with 
X-Gal for 4 hr. The data (mean f SEM) shown are the percentage of round blue cells among total number of blue cells counted. Round cells 
were confirmed to be apoptotic by propidium iodide staining of nuclei (data not shown). After transfection (12 hr), BJAB cells were cytocentrifuged, 
methanol fixed, and stained for P-galactosidase and with propidium iodide. The data shown are the percentage of apoptotic cells among the total 
number of t3-galactosidase-positive cells counted. The data were collected from at least three independent experiments. ND, not determined. 
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gous to the cytoplasmic domain of TNFR-1 (Peters and 
Lux, 1993), corroborating our observation. Why ankyrin 
contains a “death domain” remains unclear, but presum- 
ably this region is acting as a protein interaction domain. 
In vitro and in vivo binding studies show that FADD spe- 
cifically associates with the death domain of Fas, confirm- 
ing the results of the yeast interaction assay. FADD failed 
to interact with Fas-LPR and Fas-FD8, a nonsignaling 
point mutant and deletion mutant, respectively, of the Fas 
death domain. Interestingly, upon deletion of the negative 
regulatory domain of Fas, an enhanced interaction with 
FADD was observed. Hence, a correlation exists between 
the cell-killing activity of the various Fas mutants and their 
association with FADD (Figure 5A). A weak association 
between FADD and TNFR-1 was observed in vitro (Figure 
48). In addition, b-galactosidase filter assays of yeast co- 
transformed with GAUbd-Fas and GAL4ad-FADD 
turned blue within 1 hr, while those cotransformed with 
GAL4bd-TNFR-1 and GAL4ad-FADD turned blue over- 
night (the other cotransformed heterologous baits re- 
mained unchanged). If the weak interaction between 
FADD and TNFR-1 observed in yeast and in vitro proves 
to be significant, this would correlate with the relative po- 
tencies of Fas-dependent cell death and TNF-dependent 
cytotoxicity (Clement and Stamenkovic, 1994) and, fur- 
thermore, would suggest that TNFR-1 could interact with 
and utilize FADD or a FADD-like molecule as a proximal 
transducer of the death signal. 
Having shown that FADD specifically binds the death 
domain of Fas, we wished to identify the corresponding 
interaction domain in FADD. Previous studies have shown 
that death domains have a propensity to self-associate 
(Boldin et al., 1995). It was thus reasonable to propose 
that the death domain of FADD was interacting with its 
homologous counterpart in Fas. As predicted, a point 
mutation in the death domain of FADD abrogated its asso- 
ciation with Fas (Figure 8). In addition, a deletion encom- 
passing the death domain of FADD (N-FADD) also abol- 
ished binding to Fas (data not shown). Our results support 
a model in which a death domain to death domain interac- 
tion is responsible for the binding of FADD to Fas. 
Once the in vitro and in vivo association of FADD and 
Fas was established, we proceeded to determine a func- 
tional role for this novel Fas-binding protein. BJAB cells 
treated with a-Fas antibody undergo apoptosis within 
hours (M. T. and V. M. D., unpublished data), a time frame 
similar to FADD-induced killing. Likewise, CrmA-express- 
ing BJAB cells are resistant to both Fas- and FADD- 
induced killing. To ensure that the induction of cell death 
by FADD was not a peculiarity of one cell type, we also 
examined the effects of FADD on another Fas-sensitive 
cell line, MCF7. As was seen in BJAB cells, overexpres- 
sion of FADD in MCF7 cells induced apoptosis that was 
CrmA inhibitable and indistinguishable from Fas-induced 
killing. 
Deletional analysis of FADD localized the death effector 
domain of FADD to its N-terminal portion (Figure 78). In 
fact, the N-terminal amino acids (l-l 17) are sufficient to 
cause death and deletions of the N-terminus attenuate the 
cell-killing ability of FADD. In addition, the data refutes the 
possibility that FADD causes cell death by simply aggre- 
gating the Fas antigen intracellularly, since both N-FADD 
and FADDmt trigger apoptosis without binding Fas. We 
are currently investigating the intriguing possibility that 
the C-terminus of FADD can act as a dominant negative 
regulator of Fas-induced signaling. 
Overexpression of FADD induces apoptosis in a Fas 
ligand-independent fashion. A model consistent with our 
data is that endogenous FADD is associated with the death 
domain of the Fas receptor in a “resting” cell. However, 
upon ligand-mediated oligomerization of the Fas antigen, 
intracellular aggregation of the Fas death domains might 
displace FADD, triggering a death response, presumably 
mediated via the N-terminus of FADD interacting with a 
downstream component of the cell death pathway. 
Experimental Procedures 
Yeast Two-Hybrid Syste 
The cytopiasmic domains C, .-as, Fas-FDB. TNFR-1, A-TNFR-1, CD40, 
and CD28 were obtained by PCR and cloned in-frame, as confirmed 
by sequencing, into the GAL4 DNA-binding domain (GAL4bd) vector 
pASlCYH2. Full-length A20 and B94 were similarly cloned into the 
bait vector. GAL4bd-Fas was cotransformed with a prey plasmid con- 
taining a human B cell cDNA expression library fused to the GAL4 
activation domain (GAL4ad) in the PACT plasmid. A more detailed 
account of the plasmids used and the procedure for the yeast two- 
hybrid system can be found in our previous work (Hu et al., 1994). 
DNA Sequencing and Data Base Searching 
Double-stranded piasmid template was sequenced on both strands 
by the dideoxy chain termination method using modified T7 DNA poly 
merase (Sequenase, United States Biochemical Corporation). Manual 
sequencing was confirmed by subsequent automated sequencing. 
Network BLAST searches were conducted using the NCBI on-line 
service. Sequences were compared using the MegAlign (DNASTAR) 
software. 
cDNA Cloning 
A random-primed cDNA library was constructed in the pcDNA1 vector 
(Invitrogen)from TNF-cycioheximide-treated human umbilicalvein en- 
dotheliai cell poly(A)’ RNA. Colonies (5 x 105) were screened with a 
%P random-labeled Xhoi restriction fragment of the yeast prey piasmid 
encoding GAL4ad-FADD (clone 15) using standard techniques (Sam- 
brook et al., 1989) 
Northern Blot Analysis 
Adult and fetal human multiple tissue Northern blots (CLONTECH) 
were hybridized, according to the instructions of the manufacturer, 
using radiolabeled cDNA insert obtained from an Xhol digestion of 
the yeast prey plasmid encoding GAL4ad-FADD (clone 15). 
Expression Vectors 
FADD was cloned into a modified pcDNA3 expression vector (ln- 
vitrogen) in which an HA epitope tag (YPYDVPDYA) had previously 
been placed downstream of the cytomegalovirus promoter/enhancer 
(pcDNA3 HA-FADD). In addition, an AU1 epitope (DTYRYI)-tagged 
FADD and mutants were made with PCR primers encoding the epitope 
and using the FADD cDNA as template (pcDNA3 AUl-FADD). FLAG 
(DYKDDDDK)-tagged constructs of Fas and mutants were aisc made 
in pcDNA3 using full-length Fas as a template. The 5’ FLAG PCR 
primer was engineered to encode a FLAG epitope five amino acids 
downstream of the the putative signal sequence site of Fas and is as 
follows: AAG CCT GGT ACC ATG CTG GGC ATC TGG ACC CTC 
CTA CCT CTG G-IT C-i-r ACG TCT GlT GCT AGA TTA TCG TCC 
AAA GAC TAC AAG GAC GAC GAT GAC AAG AGT GTT AAT GCC 
CAA GTG. The amplified products were then cloned into the Kpni-Xhoi 
site of pcDNA3. pcDNA3 AUl-FADDmt and pcDNA3 FLAG-Fas-LPR 
were made by site-directed mutagenesis using a two-step PCR proto- 
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col (Higuchi et al., 1988). The V121+NI21 and V238-N238 muta- 
tions, respectively, were confirmed by sequence analysis. 
GST Fusion Protein Expression and In Vitro Binding Assay 
Thecytoplasmicdomainsof Fas, Fas-FD5, Fas-FD8, andTNFR-1 were 
amplified by PCR using appropriate templates and primers and cloned 
in-frame into pGSTag (Ron and Dressier, 1992). Fas-LPR was made 
by site-directed mutagenesis using a two-step PCR protocol (Higuchi 
et al., 1988) and cloned into pGSTag. The V238+N238 mutation was 
confirmed by sequence analysis. The pGSTag constructs were then 
transformed into the E. coli strain BL21(DE3)pLysS (Studier, 1991). 
GST and GST fusions were prepared using published procedures 
(Studier, 1991), and the recombinant proteins immobilized onto gluta- 
thione-agarose beads (Harper et al., 1993). 
Labeled FADD was prepared by in vitro transcription/translation 
using TNT T7-coupled reticulocyte lysate system from Promega ac- 
cording to the instructions of the manufacturer, using pcDNA3 HA- 
FADD as template. 
Following translation, equal amounts of total 3SS-labeled reticulocyte 
lysate were diluted into 150 VI of GST binding buffer (50 mM Tris [pH 
7.61, 120 mM NaCI, 1% Brij) and incubated for 2 hr at 4OC with the 
various GST fusion proteins complexed to beads, following which the 
beads were pelleted by pulse centrifugation, washed three times in 
GST buffer, boiled in SDS sample buffer, and resolved on a 10% 
SDS-polyacrylamide gel. Bound proteins were visualized following 
autoradiography at -6OOC. 
Lysates of FADD or FADDmt-transfected 293T cells were processed 
as above, except that the GST binding buffer also had 10% glycerol 
and a protease inhibitor cocktail. For some experiments, the com- 
plexed GST beads were dissociated by boiling in PBS plus 1% SDS, 
diluted IO-fold in PBS containing 1% deoxycholate, and subsequently 
subjected to immunoprecipitation analysis. 
Transfection, Metabolic Labeling, and lmmunoprecipltation 
Analysis 
These were performed essentially as described previously (O’Rourke 
et al., 1992). For reimmunoprecipitation analysis, the initial immune 
complex was dissociated by boiling in PBS plus 1% SDS, diluted lo- 
fold in PBS containing 1% deoxycholate, and subjected to a second 
round of immunoprecipitation analysis. 
Functional Assay and lmmunocytochemistry 
BJAB and MCF7 clonal cell lines stably transfected with either vector, 
CrmA, or CrmA mutant expression constructs were utilized (Tewari 
and Dixit, 1995; Tewari et al., submitted). For transient transfection 
of BJAB lines, 5 x IOn cells were electroporated at 220 V, 960 pF in 
0.4 cm cuvettes (Bio-Rad) using 20 wg of pCMV P-galactosidase plus 
or minus 30 bg of pcDNA3 AUl-FADD. After 12 hr, cells were cytocen- 
trifuged, fixed with 1% paraformaldehyde, permeabilized with 0.1% 
TritonlPBS, blocked with horse serum, and incubated with rabbit anti- 
b-galactosidase (1:200 dilution, Cappel) for 1 hr. The cells were subse- 
quently washed with PBS, incubated with biotinylated anti-rabbit anti- 
body (1:200 dilution, Vector Laboratories) for 20 min, washed with 
PBS, and incubated with Avidin-FITC (I:100 dilution, Vector Labora- 
tories) for 20 min. The nuclei were stained with a 10 pglml solution 
of propidium iodide(Sigma)for 10 min. Cellswerevisualized byfluores- 
cence microscopy using a FITC range barrier filter cube. At least 100 
B-galactosidase-positive cells were counted for each transfection 
(n = 3) and identified as apoptotic or nonapoptotic. 
MCF7 lines were transiently transfected with 5 ~1 of lipofectamine 
(GIBCO-BRL) at 50% confluency in 6-well dishes using 0.25 bg of 
pCMV &galactosidase plus or minus 1 pg of AUl-FADD or mutants. 
Transfections were carried out in 1 ml of OptiMEM Minimal Media 
(GIBCO-BRL) and incubated for 5 hr after which 1 ml of serum- 
containing growth media was added. After 24 hr, cells were fixed with 
0.5% glutaraldehyde and stained with X-Gal for 4 hr. Cells were visual- 
ized by phase-contrast microscopy. 
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GenBank Accession Number 
The accession number for the human FADD cDNA sequence reported 
in this paper is U24231. 
Note Added in Proof 
In the April 7,1995, issue of the Journal of Bblogical Chemistry, Boldin 
et al. independently utilized a Fas bait in the yeast two-hybrid system 
and cloned a cDNA that is nearly identical to the FADD cDNA. Consis- 
